Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Expert Opinion on Drug Discovery
|
July 25, 2012
Identification of targets and inhibitors of protein palmitoylation
Sonia Lobo Planey, David A Zacharias
Expert Opinion on Drug Discovery
|
September 21, 2012
The influence of lipophilicity in drug discovery and design
John A Arnott, Sonia Lobo Planey
International Journal of Cell Biology
|
April 27, 2012
Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding
David A Zacharias, Matthew Mullen, Sonia Lobo Planey
Expert Opinion on Drug Discovery
|
June 27, 2014
Targeting protein palmitoylation: selective inhibitors and implications in disease
Burzin Chavda, John A Arnott, Sonia Lobo Planey
Journal of Receptor and Signal Transduction Research
|
November 6, 2013
Estrogen receptors (ERα versus ERβ): friends or foes in human biology?
Sonia Lobo Planey, Raj Kumar, John A Arnott
BMC Biochemistry
|
September 13, 2017
Antiproliferative factor (APF) binds specifically to sites within the cytoskeleton-associated protein 4 (CKAP4) extracellular domain
Burzin Chavda, Jun Ling, Thomas Majernick, et al.
Clinical Interventions in Aging
|
September 12, 2014
Selective estrogen receptor modulators: tissue specificity and clinical utility
Stephen Martinkovich, Darshan Shah, Sonia Lobo Planey, et al.
Molecular Biology of the Cell
|
March 23, 2012
Antiproliferative factor regulates connective tissue growth factor (CTGF/CCN2) expression in T24 bladder carcinoma cells
Christina A Matika, Melissa Wasilewski, John A Arnott, et al.
Plos One
|
April 28, 2012
Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts
Max T Geisinger, Randy Astaiza, Tiffany Butler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Expert Opinion on Drug Discovery
|
July 25, 2012
Identification of targets and inhibitors of protein palmitoylation
Sonia Lobo Planey, David A Zacharias
Expert Opinion on Drug Discovery
|
September 21, 2012
The influence of lipophilicity in drug discovery and design
John A Arnott, Sonia Lobo Planey
International Journal of Cell Biology
|
April 27, 2012
Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding
David A Zacharias, Matthew Mullen, Sonia Lobo Planey
Expert Opinion on Drug Discovery
|
June 27, 2014
Targeting protein palmitoylation: selective inhibitors and implications in disease
Burzin Chavda, John A Arnott, Sonia Lobo Planey
Journal of Receptor and Signal Transduction Research
|
November 6, 2013
Estrogen receptors (ERα versus ERβ): friends or foes in human biology?
Sonia Lobo Planey, Raj Kumar, John A Arnott
BMC Biochemistry
|
September 13, 2017
Antiproliferative factor (APF) binds specifically to sites within the cytoskeleton-associated protein 4 (CKAP4) extracellular domain
Burzin Chavda, Jun Ling, Thomas Majernick, et al.
Clinical Interventions in Aging
|
September 12, 2014
Selective estrogen receptor modulators: tissue specificity and clinical utility
Stephen Martinkovich, Darshan Shah, Sonia Lobo Planey, et al.
Molecular Biology of the Cell
|
March 23, 2012
Antiproliferative factor regulates connective tissue growth factor (CTGF/CCN2) expression in T24 bladder carcinoma cells
Christina A Matika, Melissa Wasilewski, John A Arnott, et al.
Plos One
|
April 28, 2012
Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts
Max T Geisinger, Randy Astaiza, Tiffany Butler, et al.
Page
of 1